Clinical implications and prognostic values of prostate cancer susceptibility candidate methylation in primary nonmuscle invasive bladder cancer

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Kim, Young Won ^a   Yoon, Hyung Yoon ^a   Seo, Sung Pil ^a   Lee, Sang Keun ^a   Kang, Ho Won ^a   Kim, Won Tae ^a   Bang, Heui Je ^a   Ryu, Dong Hee ^a   Yun, Seok Joong ^a   Lee, Sang Cheol ^a   Kim, Wun Jae ^a   Kim, Yong June ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON MUSCLE INVASIVE BLADDER CANCER; ONCOGENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER SUSCEPTIBILITY CANDIDATE GENE; PYROSEQUENCING; RECURRENCE FREE SURVIVAL; AGED; BLADDER TUMOR; CARCINOMA; CASE CONTROL STUDY; GENETICS; PATHOLOGY; TUMOR INVASION; VERY ELDERLY;

NUCLEAR PROTEIN; PRAC PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 84930639679     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/402963     Document Type: Article

References (17)

1. M. Babjuk, M. Burger, R. Zigeuner et al., "EAU guidelines on non-muscle-invasive Urothelial carcinoma of the bladder: update 2013", European Urology, vol. 64, no. 4, pp. 639-653, 2013.
2. A. M. Kamat, P. K. Hegarty, J. R. Gee et al., "ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers", European Urology, vol. 63, no. 1, pp. 4-15, 2013.
3. W.-J. Kim and Y.-J. Kim, "Epigenetic biomarkers in urothelial bladder cancer", Expert Review of Molecular Diagnostics, vol. 9, no. 3, pp. 259-269, 2009.
4. T. Ushijima, "Detection and interpretation of altered methylation patterns in cancer cells", Nature Reviews Cancer, vol. 5, no. 3, pp. 223-231, 2005.
5. A. Besaratinia, M. Cockburn, and S. Tommasi, "Alterations of DNA methylome in human bladder cancer", Epigenetics, vol. 8, no. 10, pp. 1013-1022, 2013.
6. S. Sharma, T. K. Kelly, and P. A. Jones, "Epigenetics in cancer", Carcinogenesis, vol. 31, no. 1, pp. 27-36, 2010.
7. S. B. Baylin and P. A. Jones, "A decade of exploring the cancer epigenome-biological and translational implications", Nature Reviews Cancer, vol. 11, no. 10, pp. 726-734, 2011.
8. G. Lenka, W.-H. Weng, C.-K. Chuang, K.-F. Ng, and S.-T. Pang, "Aberrant expression of the PRAC gene in prostate cancer", International Journal of Oncology, vol. 43, no. 6, pp. 1960-1966, 2013.
9. D. C. Koestler, J. Li, J. A. Baron et al., "Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon", Modern Pathology, vol. 27, no. 1, pp. 145-155, 2014.
10. X. F. Liu, P. Olsson, C. D. Wolfgang et al., "PRAC: a novel small nuclear protein that is specifically expressed in human prostate and colon", Prostate, vol. 47, no. 2, pp. 125-131, 2001.
11. E. Arai, S. Chiku, T. Mori et al., "Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas", Carcinogenesis, vol. 33, no. 8, pp. 1487-1493, 2012.
12. Y. Tian, E. Arai, M. Gotoh, M. Komiyama, H. Fujimoto, and Y. Kanai, "Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes", BMC Cancer, vol. 14, no. 1, p. 772, 2014.
13. Y.-J. Kim, H.-Y. Yoon, J. S. Kim et al., "HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling", International Journal of Cancer, vol. 133, no. 5, pp. 1135-1142, 2013.
14. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta, "EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder", European Urology, vol. 54, no. 2, pp. 303-314, 2008.
15. S. Ali Hosseini, R. C. Sobti, K. Malekzadeh, S. K. Singh, and K. Joshi, "Frequency of P16INK4a and P14ARF genes methylation and its impact on bladder cancer cases in north Indian population", Disease Markers, vol. 28, no. 6, pp. 361-368, 2010.
16. R. Garćia-Baquero, P. Puerta, M. Beltran et al., "Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study", The Journal of Urology, vol. 190, no. 2, pp. 723-730, 2013.
17. C. T. Lee, R. L. Dunn, C. Ingold, J. E. Montie, and D. P. Wood Jr., "Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion", Urology, vol. 69, no. 6, pp. 1068-1072, 2007.